The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

51 articles for Y Lee


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into 2-aryl-1,3,4-oxadiazin-5(6H)-one.EBI
Seoul National University
Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.EBI
Seoul National University
3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitor.EBI
Yonsei University
Synthesis of quaternarya-amino acid-based arginase inhibitors via the Ugi reaction.EBI
Institutes For Pharmaceutical Discovery
Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.EBI
Yale University
Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.EBI
Seoul National University
Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors.EBI
Yonsei University
1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase.EBI
Northwestern University
Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A2A and A3 adenosine receptor ligands.EBI
Ewha Womans University
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.EBI
Neurogen
X-ray crystal structure and binding mode analysis of human S-adenosylhomocysteine hydrolase complexed with novel mechanism-based inhibitors, haloneplanocin A analogues.EBI
Ewha Womans University
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors.EBI
Konkuk University
New estrogenic compounds isolated from Broussonetia kazinoki.EBI
Sookmyung Women'S University
Structure-based virtual screening of Src kinase inhibitors.EBI
Konkuk University
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.EBI
Cytokinetics Inc
Synthesis and biological evaluation of O4'-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents.EBI
Mansoura University
Design, synthesis, and molecular modeling studies of 5'-deoxy-5'-ureidoadenosine: 5'-ureido group as multiple hydrogen bonding donor in the active site of S-adenosylhomocysteine hydrolase.EBI
Ewha Womans University
Discovery of N-(1-(2-hydroxyethyl)quinolin-2-one)-N'-(1-phenyl-1H-pyrazol-5-yl)methyl) urea as Mode-Selective TRPV1 antagonist.EBI
Seoul National University
Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer.EBI
Icahn School of Medicine At Mount Sinai
Prenylated Chrysin Derivatives as Partial PPARγ Agonists with Adiponectin Secretion-Inducing Activity.EBI
Seoul National University
Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors.EBI
University of Arizona
Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.EBI
Yonsei University College of Medicine
Discovery of (EBI
Ewha Womans University
Synthesis and insecticidal activity of fluorinated 2-(2,6-dichloro-4-trifluoromethylphenyl)-2,4,5,6-tetrahydrocyclopentapyrazoles.EBI
Johnson & Johnson Pharmaceutical Research and Development
GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the AEBI
University of Southern California
X-ray Crystal Structure-Guided Design and Optimization of 7EBI
Yonsei University
Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New AEBI
Ewha Womans University
Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity Shift.EBI
Seoul National University
Inhibition of Macrophage Migration Inhibitory Factor by a Chimera of Two Allosteric Binders.EBI
L2 Diagnostics
Discovery of a potent dual ALK and EGFR T790M inhibitor.EBI
Harvard Medical School
Syntheses of 2-[(3,5-dimethyl-4-methoxypyridyl)alkyl]-benzothiazolidine derivatives as a potential gastric H+/K(+)-ATPase inhibitor.EBI
Ajou University
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.EBI
Seoul National University
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.EBI
Seoul National University
Discovery and SAR of a series of 4,6-diamino-1,3,5-triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1.EBI
Ansaris
Isolation, Synthesis, and Antisepsis Effects of a C-Methylcoumarinochromone Isolated from Abronia nana Cell Culture.EBI
Kyungpook National University
4'-modified analogues of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase.EBI
University of Kansas
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaBDB
H. Lundbeck
SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)BDB
Dana-Farber Cancer Institute
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USEBDB
Prelude Therapeutics
Indanes as PD-L1 inhibitorsBDB
Chemocentryx
PYRAZOLOPYRIDAZINONE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFBDB
Broadenbio
N/O-Linked Degrons and Degronimers for Protein DegradationBDB
C4 Therapeutics
Apoptosis signal-regulating kinase inhibitorBDB
Gilead Sciences
4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of useBDB
TBA
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitorsBDB
Amgen
Expanding the Scope of Human DNA Polymerase ¿ and ß Inhibitors.BDB
University of Konstanz
High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations.BDB
Uppsala University
Effects of hydroxybenzyl alcohols on melanogenesis in melanocyte-keratinocyte co-culture and monolayer culture of melanocytes.BDB
National Tsing Hua University
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.BDB
Organon International
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.BDB
Acadia Pharmaceuticals